Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients
NCT04833023Phase 3Completed
- Sponsor
- Tan Tock Seng Hospital
- Start
- May 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of haloperidol, olanzapine in delirium, sponsored by Tan Tock Seng Hospital. Started May 2022; status: completed.
02
Drugs
haloperidololanzapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT04833023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833023.